mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.006 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.006 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.006 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.007 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.007 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.007 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.008 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.009 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.009 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.009 |